Molecular and Biotechnological Approaches in the Diagnosis of Leprosy
Open Access
- 6 February 2019
- book chapter
- Published by IntechOpen
Abstract
Leprosy is a worldwide health problem, which needs the development of new and innovative strategies to be controlled. Early diagnosis of leprosy is an important contribution to reducing the incidence of the disease; thus, the development of biotechnology platforms, which include the mapping of antigens with potential to be used in immunodiagnostic and molecular methods for the detection of Mycobacterium leprae, is an important tool to confirm the clinical diagnostic. Molecular biology and biotechnological methods have been used to assist in the diagnosis of this disease, each one with its advantages and drawbacks. Enzyme-linked immunosorbent assay (ELISA) is the used method for leprosy diagnosis, and it allows the detection of infection-related antigens. Alternatively, due to their versatility to perform the same functions as the protein and non-protein natural antigens, mimetic peptides are considered an important tool. On the other hand, lateral flow assay (LFA) and optical and electrochemical biosensors are rapid and portable methods, capable of performing diagnosis in the field without sample preparation. This chapter presents such techniques, their uses in the diagnosis and detection of M. leprae, as well as the potential for the development of new techniques and strategies that can help to control and understand mycobacteriosis.Keywords
This publication has 81 references indexed in Scilit:
- Lateral flow assay for simultaneous detection of cellular- and humoral immune responsesClinical Biochemistry, 2011
- Insight toward Early Diagnosis of Leprosy through Analysis of the Developing Antibody Responses of Mycobacterium leprae -Infected ArmadillosClinical and Vaccine Immunology, 2011
- Rational Design and Evaluation of a Multiepitope Chimeric Fusion Protein with the Potential for Leprosy DiagnosisClinical and Vaccine Immunology, 2010
- From Genome-Based In Silico Predictions to Ex Vivo Verification of Leprosy DiagnosisClinical and Vaccine Immunology, 2009
- Antigen-Specific T-Cell Responses of Leprosy PatientsClinical and Vaccine Immunology, 2008
- Selection of Antigens and Development of Prototype Tests for Point-of-Care Leprosy DiagnosisClinical and Vaccine Immunology, 2008
- Rational Combination of Peptides Derived from Different Mycobacterium leprae Proteins Improves Sensitivity for Immunodiagnosis of M. leprae InfectionClinical and Vaccine Immunology, 2008
- Risk and Protective Factors for Leprosy Development Determined by Epidemiological Surveillance of Household ContactsClinical and Vaccine Immunology, 2008
- The Continuing Challenges of LeprosyClinical Microbiology Reviews, 2006
- Massive gene decay in the leprosy bacillusNature, 2001